<DOC>
	<DOCNO>NCT02265965</DOCNO>
	<brief_summary>Randomized control clinical trial IV nitroglycerin cesarean delivery second stage arrest descent prevent uterine extension hysterectomy site .</brief_summary>
	<brief_title>Trial IV NTG CD After Second Stage Arrest Prevention Uterine Extension</brief_title>
	<detailed_description>Intravenous nitroglycerin result uterine relaxation standardly utilized various obstetrics condition , e.g . breech extraction second twin vaginal delivery , uterine relaxation tachysystole labor , prior external cephalic version , difficult fetal extraction cesarean delivery arrest descent labor . Currently use nitroglycerin equipoise obstetrics difficult cesarean delivery second stage arrest labor . The clinical trial randomize woman undergo cesarean delivery second stage arrest labor receive IV nitroglycerin v saline time hysterotomy . The primary outcome maternal : uterine extension , blood loss , total fetal extraction time , surgical time ; neonatal : cord gas delivery , apgar score , admission neonatal intensive care unit .</detailed_description>
	<mesh_term>Nitroglycerin</mesh_term>
	<criteria>woman 37weeks great gestation diagnose second stage arrest descent undergo cesarean delivery elective , active phase arrest cesarean delivery , successful operative vaginal delivery</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>